ASCO 2016 | Somatic genomic landscape of advanced-stage cancer patients from clinical NGS analysis of ctDNA
Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Get great new content delivered to your inboxSign up
MOUNTAINEER results: trastuzumab and tucatinib for HER2+ mCRC
Kidney cancer: post-surgery sorafenib
Melanoma news from ESMO 19
IDEA-FRANCE: ctDNA as a predictive value for adjuvant treatment duration
PARP inhibitors for ovarian cancer - room for improvement with HRD testing